TrialClinical and translational science2025

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study.

Avner Sandhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.